Mohammed Al Jumayli in Tampa, Florida

Home Florida Tampa

Mohammed Al Jumayli has Medical Oncology as her primary medical specialty. Their primary office is: 12902 Usf Magnolia Dr in Tampa, Florida.

They're a part of the: H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc medical group which has around 892 members. You can call their office at 888-860-2778 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1999 (around 25 years of experience). They are listed as doing telehealth appointments.

Mohammed Al Jumayli Office Phone and Directions

Mohammed Al Jumayli
H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc
12902 Usf Magnolia Dr
Tampa, Florida 33612
888-860-2778

Patient Ratings
Please rate your experience with Mohammed Al Jumayli below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 888-860-2778

Enter a starting address:

Healthcare Info for Mohammed Al Jumayli

Medical School: Sorry, her university is not listed
Graduation Year: 1999
The Primary Medical Specialty for Mohammed Al Jumayli is listed as: Medical Oncology
Approximate Years of Experience: 25
PAC (PECOS ID)#: 7315219136
NPI #: 1083964878
NPI Created On: 09/19/2012
NPI Last Updated Listed as: 12/17/2021
Primary Taxonomy Code: 207R00000X
License Number:
NJ PERMIT
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

New patient office or other outpatient visit, typically 60 minutes
Prolonged patient service without direct patient contact first hour

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $44

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 801077135

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99